StockSelector.com
  Research, Select, & Monitor Wednesday, September 26, 2018 10:44:37 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Harvard Bioscience Inc.$5.02($.03)(.59%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Harvard Bioscience Inc. has an overall rank of 361 out of 7264 stocks based on 14 positive rankings and 7 negative rankings.

Positive Rankings
Oversold RSI
The 14 Day Relative-Strength Index for Harvard Bioscience Inc. is 25.2. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Harvard Bioscience Inc. is ranked 76.
Estimated EPS Growth
Harvard Bioscience Inc. rank is 83
Low Put/Call
Harvard Bioscience Inc. has a low Put/Call ratio of 0.06 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Harvard Bioscience Inc. is ranked 162.
PEGValue
Harvard Bioscience Inc. has a PEG Value of $9.45. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 87.13% in the next year. Among companies with a PEG Value above the current stock price, Harvard Bioscience Inc. is ranked 316.
Low vPut/Call
Harvard Bioscience Inc. has a low Put/Call ratio of 0.16 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Harvard Bioscience Inc. is ranked 384.
SSValue
The StockSelector Value for Harvard Bioscience Inc. is $8.21. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Harvard Bioscience Inc. is ranked 510.
Top Industry Values
Harvard Bioscience Inc. rank is 619
Oversold Stochastics
Harvard Bioscience Inc. rank is 728
Debt-to-Equity
Harvard Bioscience Inc. rank is 791
Up EPS Surprise
Harvard Bioscience Inc. beat the consensus earnings estimate when it last reported quarterly earnings.
Estimated Revenue Growth
Harvard Bioscience Inc. rank is 928
90 Day Gain
Harvard Bioscience Inc. rank is 1268
Price-to-Sales
Harvard Bioscience Inc. rank is 2134
Highest Net Margin
Harvard Bioscience Inc. rank is 3157
Negative Rankings
10 Day Loss
Harvard Bioscience Inc. rank is 357
Negative Cash Growth
Harvard Bioscience Inc. rank is 456
Negative Past Growth
Harvard Bioscience Inc. rank is 635
Negative Revenue Growth
Harvard Bioscience Inc. rank is 1092
Negative ROE
Harvard Bioscience Inc. rank is 1587
Negative ROA
Harvard Bioscience Inc. rank is 1854
Price-to-Book
Harvard Bioscience Inc. rank is 2343







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.